Source https://www.fightaging.org/archives/2021/11/an-example-of-the-growth-in-investment-funds-dedicated-to-the-longevity-industry/
Cambrian Biopharma started as a venture fund, but is a business development company now. The most important difference between those two business models is that a fund waits for startup companies to form and be ready for investment, while a development company sets out to create startups. The longevity industry is still comparatively small, and the arrival of new investment opportunities is thought by many, including the Cambrian Biopharma principals, to be too sparse to sustain larger funds. The solution, in an environment rich with promising scientific projects, is to create those opportunities: bring together scientists and entrepreneurs, license the relevant technologies from the universities, and fund the resulting startup company.
As noted in today’s publicity materials, Cambrian has assembled a s…
Source https://www.fightaging.org/archives/2021/11/an-example-of-the-growth-in-investment-funds-dedicated-to-the-longevity-industry/
Cambrian Biopharma started as a venture fund, but is a business development company now. The most important difference between those two business models is that a fund waits for startup companies to form and be ready for investment, while a development company sets out to create startups. The longevity industry is still comparatively small, and the arrival of new investment opportunities is thought by many, including the Cambrian Biopharma principals, to be too sparse to sustain larger funds. The solution, in an environment rich with promising scientific projects, is to create those opportunities: bring together scientists and entrepreneurs, license the relevant technologies from the universities, and fund the resulting startup company.
As noted in today’s publicity materials, Cambrian has assembled a s…
What Do You Think?
comments